EFOMP's protocol quality controls in PET/CT and PET/MR.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 29 06 2022
revised: 25 11 2022
accepted: 26 11 2022
pubmed: 21 12 2022
medline: 18 1 2023
entrez: 20 12 2022
Statut: ppublish

Résumé

This article presents the protocol on Quality Controls in PET/CT and PET/MRI published online in May 2022 by the European Federation of Organisations for Medical Physics (EFOMP), which was developed by the Working group for PET/CT and PET/MRI Quality Control (QC) protocol. The main objective of this protocol was to comprehensively provide simple and practical procedures that may be integrated into clinical practice to identify changes in the PET/CT/MRI system's performance and avoid short- and long-term quality deterioration. The protocol describes the quality control procedures on radionuclide calibrators, weighing scales, PET, CT and MRI systems using selected and measurable parameters that are directly linked to clinical images quality. It helps to detect problems before they can impact clinical studies in terms of safety, image quality, quantification accuracy and patient radiation dose. CT and MRI QCs are described only in the context of their use for PET (attenuation correction and anatomical localization) imaging. Detailed step-by-step instructions have been provided, limiting any misinterpretations or interpersonal variations as much as possible. This paper presents the main characteristics of the protocol illustrated together with a brief summary of the content of each chapter. A regular QC based on the proposed protocol would guarantee that PET/CT and PET/MRI systems operate under optimal conditions, resulting in the best performance for routine clinical tasks.

Identifiants

pubmed: 36538846
pii: S1120-1797(22)02101-9
doi: 10.1016/j.ejmp.2022.11.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102506

Informations de copyright

Copyright © 2022 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Roberta Matheoud (R)

Medical Physics Department, University Hospital Maggiore della Carità, Novara, Italy. Electronic address: roberta.matheoud@maggioreosp.novara.it.

Ronald Boellaard (R)

Radiology and Nuclear Medicine, Cancer Center Amsterdam UMC, location VUMC, Amsterdam, the Netherlands; Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, the Netherlands.

Lucy Pike (L)

King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK.

Jaroslav Ptacek (J)

Department of Medical Physics and Radiation Protection, University Hospital Olomouc, Olomouc, Czech Republic.

Gabriel Reynés-Llompart (G)

Medical Physics Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.

Marine Soret (M)

Service de Médecine Nucléaire and LIB, Sorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles Foix, INSERM U1146, Paris, France.

Stefaan Vandenberghe (S)

Medical Image and Signal Processing, Ghent University, Belgium.

Alessandra Zorz (A)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

Peter Julyan (P)

Christie Medical Physics & Engineering, The Christie NHS Foundation Trust, Withington, Manchester, UK.

Ivo Rausch (I)

Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Austria.

Bernhard Sattler (B)

Department of Nuclear Medicine, Leipzig University Hospital, Liebigstr. 18, Leipzig, Germany.

Sanchez-Garcia Manuel (SG)

Department of Medical Physics and Radiological Protection, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.

Giovanni Tosi (G)

IRCCS Humanitas Research Hospital, Rozzano, Italy.

Kostantinos Dalianis (K)

Medical Physics Department Hygeia Hospital SA, Athens, Greece.

Pedro Miguel Dinis Almeida (PMD)

Instituto de Biofísica e Engenharia Biomédica e Departamento de Física, Faculdade de Ciências da Universidade de Lisboa, Campo Grande, Lisboa, Portugal.

Cinzia Fabbri (C)

Medical Physics and Biomedical Engineering, AUSL Romagna, Cesena, Italy.

Joanna Gawel (J)

Medical Physics Department, Affidea Cancer Treatment Centre in Wałbrzych, Wałbrzych, Poland.

Panayiotis Hadjitheodorou (P)

Medical Physics Department, German Oncology Center, Limassol, Cyprus.

Maria Kotzasarlidou (M)

Medical Physics Department, Theageneio Hospital, Thessaloniki, Greece.

Thiago Viana Miranda Lima (T)

Department of Radiology and Nuclear Medicine, Cantonal Hospital Lucerne, Lucerne, Switzerland.

Jim O'Doherty (J)

Siemens Medical Solutions, Malvern, PA, United States; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, United States.

Kirill Skovorodko (K)

State Research Institute Center for Physical Sciences and Technology (FTMC), Savanorių Ave. 231, 02300 Vilnius, Lithuania.

Dmitri Sutov (D)

Tartu University Hospital, Tartu, Estonia.

Ahmed Taher (A)

Nuclear Medicine and Cyclotron, King Hamad University Hospital, Busaiteen, Bahrain.

Marco Valenti (M)

Medical Physics Department, AOU Ospedali Riunti Ancona.

Eleonora Vanzi (E)

Medical Physics Unit, Siena University Hospital, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH